research Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral‐nerve injury: An advantageous alternative to ES and iPS cells
Human hair follicle stem cells can safely and effectively help nerve regeneration.
Search
forLearn
0 / 0 results — no results
Research
5 / 263 resultsresearch The TRF1 Telomere Protein Is Essential for the Generation and Maintenance of Induced Pluripotent Stem Cells and Marks Both Pluripotent and Adult Stem Cells
TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.
research Regeneration of a Bioengineered 3D Integumentary Organ System from iPS Cells
Scientists created a functional 3D skin system from stem cells that can be transplanted into wounds.
research Generation of iPS Cells from Human Hair Follicle Dermal Papilla Cells
Researchers made stem cells from human hair follicle cells with higher efficiency than from skin cells.
research Bioengineering a 3D Integumentary Organ System from iPS Cells Using an In Vivo Transplantation Model
Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.
Community Join
3 / 3 resultscommunity Is there any word on when Stempsen Therapeutics and Hairclone will start phase 1 clinical trials?
Hair cloning trials by Stempsen Therapeutics and Hairclone have no updates, and it may take at least 15 years for hair cloning to be available. The conversation also mentions treatments like Minoxidil, finasteride, and RU58841.
community Prediction: Scube3 is never coming out
Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.
community Dr. Tsuji and Riken to make important announcement on their hair cloning cure on Feb 10th.
Dr. Tsuji and Riken announced a hair cloning cure with a 98.9% success rate, expected to be released in 10 years. Users expressed hope and skepticism about the affordability and timeline of the treatment.